Oligodendroglial cell differentiation in rat brain is accelerated by the intracranial injection of apotransferrin.
In the present paper we first studied the brain distribution and the time and dose dependent effects of apotransferrin, after its intracranial injection into young rats and at different post-natal ages. Its action upon the transferrin receptor (TfR) and upon the expression of brain transferrin, as well as its effect on the proliferation and differentiation of oligodendroglial cells (OLGc) was one of the main objectives of our investigation. Total DNA and BrdU labeling, as an index of cellularity and proliferation, respectively, were the same in the control and experimental groups of rats. A significant increase in the MBP+ and CA II+ OLGc, and a decrease in the more immature (A2B5+) OLGc were found in the aTf injected rats. At 10 and 17 days of age, Tf-mRNA decreased to around 20% of the amount present in control animals. The TfR-mRNA in the animals receiving a single dose of aTf at 3 days of age showed an increase in its expression at 10 and 17 days of age, coincident with a higher immunoreactivity of the TfR itself of neurons, choroid plexus and brain capillaries in different brain areas. Although TfR+ OLGc were present up to 7 days of age in controls and in the Tf injected rats, no positive cells were observed at 17 days of age, even in the aTf injected rats. Our results give support to the hypothesis that aTf is an important factor necessary for the maturation of the OLGc, and that the effects that it produces in the OLGc-myelin unit after its intracranial injection in young rats are not due to an increase in proliferation, but to an accelerated differentiation of Tf-sensitive OLGc.
Marta
C B
CB
Departamento de Química Biológica and Instituto de Química y Fisicoquímica Biológica (IQUIFIB, UBA-CONICET), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina. edufsoto@mail.retina.ar
Escobar Cabrera
O E
OE
Garcia
C I
CI
Villar
M J
MJ
Pasquini
J M
JM
Soto
E F
EF
D000818:Animals; D001059:Apoproteins / Q000008:administration & dosage / Q000235:genetics / Q000494:pharmacology*; D001921:Brain / Q000166:cytology / Q000378:metabolism*; D002454:Cell Differentiation; D004305:Dose-Response Relationship, Drug; D005260:Female; D015870:Gene Expression; D006801:Humans; D007267:Injections; D007457:Iodine Radioisotopes / Q000378:metabolism; D008297:Male; D009836:Oligodendroglia / Q000166:cytology* / Q000378:metabolism; D012333:RNA, Messenger; D051381:Rats; D017208:Rats, Wistar; D011990:Receptors, Transferrin / Q000235:genetics; D012886:Skull; D013997:Time Factors; D014168:Transferrin / Q000008:administration & dosage / Q000235:genetics / Q000494:pharmacology*
D001059:Apoproteins; D007457:Iodine Radioisotopes; D012333:RNA, Messenger; D011990:Receptors, Transferrin; D014168:Transferrin; C028284:apotransferrin